Via Pharmaceuticals Stock Forecast - Simple Regression
| VIAP Stock | USD 0.0005 0.00 0.00% |
The Simple Regression forecasted value of Via Pharmaceuticals on the next trading day is expected to be 0.0005 with a mean absolute deviation of 0 and the sum of the absolute errors of 0. Via Stock Forecast is based on your current time horizon. Although Via Pharmaceuticals' naive historical forecasting may sometimes provide an important future outlook for the firm, we recommend always cross-verifying it against solid analysis of Via Pharmaceuticals' systematic risk associated with finding meaningful patterns of Via Pharmaceuticals fundamentals over time.
As of today the rsi of Via Pharmaceuticals' share price is below 20 . This entails that the stock is significantly oversold. The fundamental principle of the Relative Strength Index (RSI) is to quantify the velocity at which market participants are driving the price of a financial instrument upwards or downwards. Momentum 0
Sell Peaked
Oversold | Overbought |
Wall Street Target Price 5 |
Using Via Pharmaceuticals hype-based prediction, you can estimate the value of Via Pharmaceuticals from the perspective of Via Pharmaceuticals response to recently generated media hype and the effects of current headlines on its competitors.
The Simple Regression forecasted value of Via Pharmaceuticals on the next trading day is expected to be 0.0005 with a mean absolute deviation of 0 and the sum of the absolute errors of 0. Via Pharmaceuticals after-hype prediction price | USD 5.0E-4 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Historical Fundamental Analysis of Via Pharmaceuticals to cross-verify your projections. Via Pharmaceuticals Additional Predictive Modules
Most predictive techniques to examine Via price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Via using various technical indicators. When you analyze Via charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Via Pharmaceuticals Simple Regression Price Forecast For the 25th of January
Given 90 days horizon, the Simple Regression forecasted value of Via Pharmaceuticals on the next trading day is expected to be 0.0005 with a mean absolute deviation of 0, mean absolute percentage error of 0, and the sum of the absolute errors of 0.Please note that although there have been many attempts to predict Via Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Via Pharmaceuticals' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Via Pharmaceuticals Stock Forecast Pattern
| Backtest Via Pharmaceuticals | Via Pharmaceuticals Price Prediction | Buy or Sell Advice |
Via Pharmaceuticals Forecasted Value
In the context of forecasting Via Pharmaceuticals' Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Via Pharmaceuticals' downside and upside margins for the forecasting period are 0.0005 and 0.0005, respectively. We have considered Via Pharmaceuticals' daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Simple Regression forecasting method's relative quality and the estimations of the prediction error of Via Pharmaceuticals stock data series using in forecasting. Note that when a statistical model is used to represent Via Pharmaceuticals stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 33.6272 |
| Bias | Arithmetic mean of the errors | None |
| MAD | Mean absolute deviation | 0.0 |
| MAPE | Mean absolute percentage error | 0.0 |
| SAE | Sum of the absolute errors | 0.0 |
Predictive Modules for Via Pharmaceuticals
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Via Pharmaceuticals. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Via Pharmaceuticals After-Hype Price Prediction Density Analysis
As far as predicting the price of Via Pharmaceuticals at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Via Pharmaceuticals or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Via Pharmaceuticals, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Via Pharmaceuticals Estimiated After-Hype Price Volatility
In the context of predicting Via Pharmaceuticals' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Via Pharmaceuticals' historical news coverage. Via Pharmaceuticals' after-hype downside and upside margins for the prediction period are 0.00 and 0.00, respectively. We have considered Via Pharmaceuticals' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Via Pharmaceuticals is very steady at this time. Analysis and calculation of next after-hype price of Via Pharmaceuticals is based on 3 months time horizon.
Via Pharmaceuticals Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Via Pharmaceuticals is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Via Pharmaceuticals backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Via Pharmaceuticals, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.00 | 0.00 | 0.00 | 0.00 | 9 Events / Month | 3 Events / Month | In about 9 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
0.0005 | 0.0005 | 0.00 |
|
Via Pharmaceuticals Hype Timeline
Via Pharmaceuticals is at this time traded for 0.0005. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Via is forecasted not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is forecasted to be very small, whereas the daily expected return is at this time at 0.0%. %. The volatility of related hype on Via Pharmaceuticals is about 0.0%, with the expected price after the next announcement by competition of 0.00. The company has Price to Book (P/B) ratio of 1.89. Historically many companies with similar price-to-book (P/B) ratio do better than the market in the long run. Via Pharmaceuticals recorded a loss per share of 0.01. The entity had not issued any dividends in recent years. The firm had 1:15 split on the 6th of June 2007. Given the investment horizon of 90 days the next forecasted press release will be in about 9 days. Check out Historical Fundamental Analysis of Via Pharmaceuticals to cross-verify your projections.Via Pharmaceuticals Related Hype Analysis
Having access to credible news sources related to Via Pharmaceuticals' direct competition is more important than ever and may enhance your ability to predict Via Pharmaceuticals' future price movements. Getting to know how Via Pharmaceuticals' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Via Pharmaceuticals may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| OLMM | OneLife Technologies Corp | 0.00 | 2 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| LFPI | LifePoint | 0.00 | 12 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| HLTT | Healthtech Solutions | 0.00 | 9 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| IXSBF | InNexus Biotechnology | 0.00 | 2 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| TRVN | Trevena | 0.00 | 6 per month | 0.00 | 0.11 | 0.00 | 0.00 | 1,000.00 | |
| ICCT | iCoreConnect Common stock | (0.0009) | 14 per month | 31.13 | 0.21 | 250.00 | (72.73) | 540.00 | |
| WPHM | Winston Pharmaceuticals | 0.00 | 1 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| AFIB | Acutus Medical | 0.00 | 0 per month | 0.00 | 0.17 | 100.00 | (70.00) | 2,997 | |
| EVLO | Evelo Biosciences | 0.00 | 0 per month | 0.00 | 0.07 | 0.00 | (20.00) | 460.00 | |
| ALST | Allstar Health Brands | (0.0005) | 3 per month | 7.93 | 0.06 | 25.00 | (20.00) | 70.00 |
Other Forecasting Options for Via Pharmaceuticals
For every potential investor in Via, whether a beginner or expert, Via Pharmaceuticals' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Via Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Via. Basic forecasting techniques help filter out the noise by identifying Via Pharmaceuticals' price trends.Via Pharmaceuticals Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Via Pharmaceuticals stock to make a market-neutral strategy. Peer analysis of Via Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Via Pharmaceuticals by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Via Pharmaceuticals Market Strength Events
Market strength indicators help investors to evaluate how Via Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Via Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Via Pharmaceuticals stock market strength indicators, traders can identify Via Pharmaceuticals entry and exit signals to maximize returns.
| Rate Of Daily Change | 1.0 | |||
| Day Median Price | 5.0E-4 | |||
| Day Typical Price | 5.0E-4 |
Story Coverage note for Via Pharmaceuticals
The number of cover stories for Via Pharmaceuticals depends on current market conditions and Via Pharmaceuticals' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Via Pharmaceuticals is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Via Pharmaceuticals' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Additional Tools for Via Stock Analysis
When running Via Pharmaceuticals' price analysis, check to measure Via Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Via Pharmaceuticals is operating at the current time. Most of Via Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Via Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Via Pharmaceuticals' price. Additionally, you may evaluate how the addition of Via Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.